Alkermes (ALKS) Cash & Current Investments (2010 - 2026)

Alkermes' (ALKS) quarterly Cash & Current Investments came in at $511.9 million in Q1 2026, down 42.1% year-on-year from $884.0 million in Q1 2025, and down 54.29% on a QoQ basis from $1.1 billion in Q4 2025.

Alkermes (ALKS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Cash & Current Investments data on file, last reported at $511.9 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 42.1% year-over-year to $511.9 million in Q1 2026; TTM through Mar 2026 was $511.9 million, a 42.1% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 48.97% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $511.9 million, down from $1.1 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for ALKS reached as high as $1.1 billion in Q4 2025 and fell as low as $511.9 million in Q1 2026.
  • Historically, Cash & Current Investments has averaged $783.2 million across 5 years, with a median of $773.5 million in 2023.
  • Across the five-year window, Cash & Current Investments jumped 53.25% in 2023 and sank 42.1% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $608.5 million in 2022, then grew by 27.12% to $773.5 million in 2023, then declined by 2.82% to $751.7 million in 2024, then jumped by 48.97% to $1.1 billion in 2025, then plunged by 54.29% to $511.9 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $511.9 million in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.15 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 511.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 511.86 Mn
Dec 31, 2025 1.12 Bn
Sep 30, 2025 1.11 Bn
Jun 30, 2025 1.02 Bn
Mar 31, 2025 884.02 Mn
Dec 31, 2024 751.67 Mn
Sep 30, 2024 908.86 Mn
Jun 30, 2024 876.12 Mn
Mar 31, 2024 745.05 Mn
Dec 31, 2023 773.49 Mn
Sep 30, 2023 889.15 Mn
Jun 30, 2023 829.05 Mn
Mar 31, 2023 600.46 Mn
Dec 31, 2022 608.47 Mn
Sep 30, 2022 580.18 Mn
Jun 30, 2022 580.97 Mn
Mar 31, 2022 528.87 Mn
Dec 31, 2021 536.31 Mn
Sep 30, 2021 560.30 Mn
Jun 30, 2021 538.35 Mn